{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:52:08Z","timestamp":1779936728637,"version":"3.53.1"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1097\/md.0000000000006583","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T14:34:37Z","timestamp":1491921277000},"page":"e6583","source":"Crossref","is-referenced-by-count":67,"title":["Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy"],"prefix":"10.1097","volume":"96","author":[{"given":"Yong-Chao","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210226","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"R2-21-20210226","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.ajkd.2011.09.017","article-title":"Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database","volume":"59","author":"Packham","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R3-21-20210226","doi-asserted-by":"crossref","first-page":"172038","DOI":"10.1155\/2015\/172038","article-title":"Effect of sulodexide on urinary biomarkers of kidney injury in normoalbuminuric type 2 diabetes: a randomized controlled trial","volume":"2015","author":"Satirapoj","year":"2015","journal-title":"J Diabetes Res"},{"key":"R4-21-20210226","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"Parving","year":"2012","journal-title":"N Engl J Med"},{"key":"R5-21-20210226","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N Engl J Med"},{"key":"R6-21-20210226","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000075627","article-title":"Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy","volume":"24","author":"Bolton","year":"2004","journal-title":"Am J Nephrol"},{"key":"R7-21-20210226","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/dmrr.2659","article-title":"The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy","volume":"31","author":"Lv","year":"2015","journal-title":"Diabetes\/Metab Res Rev"},{"key":"R8-21-20210226","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1681\/ASN.2007091048","article-title":"The role of inflammatory cytokines in diabetic nephropathy","volume":"19","author":"Navarro-Gonzalez","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R9-21-20210226","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1464-5491.2001.00413.x","article-title":"Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with type 1 diabetes mellitus with diabetic nephropathy","volume":"18","author":"Korpinen","year":"2001","journal-title":"Diabetic Med"},{"key":"R10-21-20210226","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ki.1996.162","article-title":"Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus","volume":"49","author":"Iwano","year":"1996","journal-title":"Kidney Int"},{"key":"R11-21-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI115821","article-title":"Transforming growth factor-beta in disease: the dark side of tissue repair","volume":"90","author":"Border","year":"1992","journal-title":"J Clin Investig"},{"key":"R12-21-20210226","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N Engl J Med"},{"key":"R13-21-20210226","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0026-0495(00)90264-6","article-title":"Activation of transforming growth factor-beta1 in diabetic kidney disease","volume":"49","author":"Hellmich","year":"2000","journal-title":"Metab Clin Exp"},{"key":"R14-21-20210226","first-page":"519","article-title":"Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus","volume":"28","author":"Ibrahim","year":"2007","journal-title":"Saudi Med J"},{"key":"R15-21-20210226","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1177\/0960327112470274","article-title":"Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy","volume":"32","author":"Shaker","year":"2013","journal-title":"Hum Exp Toxicol"},{"key":"R16-21-20210226","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1590\/S0100-879X1999001200011","article-title":"Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy","volume":"32","author":"Rivarola","year":"1999","journal-title":"Braz J Med Biol Res"},{"key":"R17-21-20210226","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4161\/adip.26553","article-title":"Adiponectin and IL-6: mediators of inflammation in progression of healthy to type 2 diabetes in Indian population","volume":"3","author":"Upadhyaya","year":"2014","journal-title":"Adipocyte"},{"key":"R18-21-20210226","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clim.2016.08.004","article-title":"Changes of regulatory T cells, transforming growth factor-beta and interleukin-10 in patients with type 1 diabetes mellitus: A systematic review and meta-analysis","volume":"170","author":"Qiao","year":"2016","journal-title":"Clin Immunol"},{"key":"R19-21-20210226","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R21-21-20210226","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/gepi.20048","article-title":"Heterogeneity testing in meta-analysis of genome searches","volume":"28","author":"Zintzaras","year":"2005","journal-title":"Genet Epidemiol"},{"key":"R22-21-20210226","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R23-21-20210226","doi-asserted-by":"crossref","first-page":"3694957","DOI":"10.1155\/2016\/3694957","article-title":"Changes of regulatory T cells and of proinflammatory and immunosuppressive cytokines in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"2016","author":"Qiao","year":"2016","journal-title":"J Diabetes Res"},{"key":"R24-21-20210226","first-page":"1128","article-title":"Infect of pingshen decoction on serum HGF, Cys C and TGF-beta1 diabetic nephropathy in early stage","volume":"39","author":"Liu","year":"2014","journal-title":"J Immunol Res"},{"key":"R25-21-20210226","first-page":"793","article-title":"The level about the TGF-\u03b21 and proto-oncogene proteins c-sis in peripheral blood of T2DM patients with nephropathy and the clinical applications (in Chinese)","volume":"22","author":"Jun-Wen","year":"2007","journal-title":"Clin Focus"},{"key":"R26-21-20210226","first-page":"402","article-title":"Association of serum transforming growth factor-(TGF-\u03b21), type IV collagen and laminin with diabetic nephropathy in type 2 diabetic patients (in Chinese)","volume":"26","author":"Chi","year":"2013","journal-title":"Heilongjiang Med J"},{"key":"R27-21-20210226","first-page":"471","article-title":"Clinical significance of determination of serum cystatin C, transforming growth factor beta1(TGF-\u03b21) and urine microalbumin levels in patients with DM2 nephropathy (in Chinese)","volume":"20","author":"Changxin","year":"2007","journal-title":"J Radionimmunol"},{"key":"R28-21-20210226","first-page":"286","article-title":"The change of serum and urinary transforming growth factor-beta-1 and their clinical significances in type 2 diabetics (in Chinese)","volume":"9","author":"Jing","year":"2005","journal-title":"Chin J Lab Diagn"},{"key":"R29-21-20210226","first-page":"530","article-title":"Clinical study of serum matrix metalloproteinase-9 and transforming growth factor-\u03b21 related with type 2 diabetic patients with nephropathy (in Chinese)","volume":"26","author":"Zhen-zuo","year":"2005","journal-title":"J Taishan Med Coll"},{"key":"R30-21-20210226","first-page":"1806","article-title":"The level about the HGF and TGF-\u03b21 in peripheral blood of T2DM patients with nephropathy and the clinical applications (in Chinese)","volume":"33","author":"Rui-ji","year":"2011","journal-title":"Hebei Med J"},{"key":"R31-21-20210226","first-page":"214","article-title":"Determination and clinical significance analysis of IL-6, TNF-\u03b2 and TGF-\u03b21 in the patients with diabetic nephropathy (in Chinese)","volume":"18","author":"Yan-jun","year":"2002","journal-title":"Chin J Sci Techn Periodicals"},{"key":"R32-21-20210226","first-page":"173","article-title":"The serum level and the genotype of TGF-\u03b21 in patients with type 2 diabetic nephropathy (in Chinese)","volume":"128","author":"Ye-Sheng","year":"2005","journal-title":"Chin J Lab Med"},{"key":"R33-21-20210226","first-page":"9838","article-title":"Association between changes in transforming growth factor-beta1 level and type 2 diabetic nephropathy (in Chinese)","volume":"11","author":"Wei-jie","year":"2007","journal-title":"J Clin Rehabil Tissue Eng Res"},{"key":"R34-21-20210226","first-page":"441","article-title":"Relationship between serum levels of transforming growth factor-\u03b21, tumor necrosis factor-\u03b2 and diabetic nephropathy (in Chinese)","volume":"34","author":"Zhou","year":"2005","journal-title":"Acta Med Univ Sci Technol Huazhong"},{"key":"R35-21-20210226","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.diabres.2004.01.007","article-title":"Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy","volume":"65","author":"Ha","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"R36-21-20210226","first-page":"202","article-title":"Clinical significance of urinary transforming growth factor-\u03b21 measurement in diabetics (in Chinese)","volume":"38","author":"Chun-Yan","year":"2003","journal-title":"Acta Univ Med Nahui"},{"key":"R37-21-20210226","first-page":"743","article-title":"Clinical significance of Urinary transforming growth factor-\u03b21 measurement in type 2 diabetic nephropathy","volume":"26","author":"Yun-hai","year":"2013","journal-title":"J Radionimmunol"},{"key":"R38-21-20210226","first-page":"940","article-title":"Urinalysis of transforming growth factor-\u03b21 in old patients with diabetic nephropathy","volume":"11","author":"Jian-jian","year":"2005","journal-title":"Chin J Rehabil Theory Pract"},{"key":"R39-21-20210226","first-page":"450","article-title":"Correlation of serum TGF-\u03b21 and PDGF-BB with albumin excretion rate in patients with type 2 diabetic nephropathy (in Chinese)","volume":"47","author":"Dong","year":"2011","journal-title":"Acta Acad Med Qingdao Univ"},{"key":"R40-21-20210226","first-page":"16","article-title":"The change and the implication of urinary VEGF, TGF\u03b21 and Co-IV level in type 2 diabetic patients with nephropathy (in Chinese)","volume":"33","author":"Jian-hong","year":"2004","journal-title":"Bull Med Res"},{"key":"R41-21-20210226","first-page":"1362","article-title":"The detection and clinical significance of serum and urinary transforming growth factor-\u03b21 measurement in type 2 diabetic nephropathy (in Chinese)","volume":"19","author":"Wei-min","year":"2004","journal-title":"Clin Focus"},{"key":"R42-21-20210226","first-page":"399","article-title":"The correlation research about urinary microalbuminuria, and TGF-\u03b21 in early diabetic nephropathy (in Chinese)","volume":"22","author":"Tao","year":"2006","journal-title":"J Pract Med"},{"key":"R43-21-20210226","first-page":"972","article-title":"Clinical significance of determination of transforming growth factor beta 1, tumor necrosis factor alpha and urine microalbumin levels in patients with DM2 nephropathy (in Chinese)","volume":"25","author":"Wei-kang","year":"2008","journal-title":"J Clin Res"},{"key":"R44-21-20210226","doi-asserted-by":"crossref","first-page":"S424","DOI":"10.1055\/s-2001-18600","article-title":"Pathogenesis of diabetic nephropathy","volume":"109","author":"Raptis","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R45-21-20210226","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/S0270-9295(03)00132-3","article-title":"Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up","volume":"23","author":"Chen","year":"2003","journal-title":"Semin Nephrol"},{"key":"R46-21-20210226","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology"},{"key":"R47-21-20210226","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1902\/jop.2008.080246","article-title":"The role of inflammatory cytokines in diabetes and its complications","volume":"79","author":"King","year":"2008","journal-title":"J Periodontol"},{"key":"R48-21-20210226","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.90.5.1814","article-title":"Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy","volume":"90","author":"Yamamoto","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"R49-21-20210226","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2337\/diab.46.5.854","article-title":"Increased renal production of transforming growth factor-beta1 in patients with type II diabetes","volume":"46","author":"Sharma","year":"1997","journal-title":"Diabetes"},{"key":"R50-21-20210226","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.mcna.2004.04.012","article-title":"Diabetic nephropathy and retinopathy","volume":"88","author":"Jawa","year":"2004","journal-title":"Med Clin N Am"},{"key":"R51-21-20210226","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJMcp011773","article-title":"Clinical practice. Nephropathy in patients with type 2 diabetes","volume":"346","author":"Remuzzi","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000006583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:47:19Z","timestamp":1620960439000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201704140-00021"}},"subtitle":["A PRISMA-compliant systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":50,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006583","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}